Vita Life Sciences Ltd
ASX:VLS

Watchlist Manager
Vita Life Sciences Ltd Logo
Vita Life Sciences Ltd
ASX:VLS
Watchlist
Price: 2.29 AUD 1.78%
Market Cap: 126.4m AUD

Gross Margin
Vita Life Sciences Ltd

59.4%
Current
59%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.4%
=
Gross Profit
47.2m
/
Revenue
79.5m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
AU
Vita Life Sciences Ltd
ASX:VLS
129.5m AUD
59%
US
Eli Lilly and Co
NYSE:LLY
754.8B USD
82%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
US
Johnson & Johnson
NYSE:JNJ
376.3B USD
68%
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK
84%
CH
Roche Holding AG
SIX:ROG
204.5B CHF
74%
CH
Novartis AG
SIX:NOVN
188.6B CHF
76%
UK
AstraZeneca PLC
LSE:AZN
165.3B GBP
82%
US
Merck & Co Inc
NYSE:MRK
210.7B USD
78%
IE
Endo International PLC
LSE:0Y5F
184.8B USD
68%
US
Pfizer Inc
NYSE:PFE
144.9B USD
75%

Vita Life Sciences Ltd
Glance View

Market Cap
129.5m AUD
Industry
Pharmaceuticals

Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-23. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth, VitaScience and VitaLife. The firm operates in Australia, Singapore, Malaysia and others. The firm subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, VitaHealth Laboratories Australia Pty Limited and Vita Institute of Health Pty Ltd.

VLS Intrinsic Value
2.42 AUD
Undervaluation 6%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.4%
=
Gross Profit
47.2m
/
Revenue
79.5m
What is the Gross Margin of Vita Life Sciences Ltd?

Based on Vita Life Sciences Ltd's most recent financial statements, the company has Gross Margin of 59.4%.

Back to Top